CAROLINE COLOZZI: Open Payments
NPI 1144516840 · STONEHAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,101 in 18 payments from 9 companies in 2025. Trend: 2023 $323 · 2024 $2,214 · 2025 $1,101
Food & beverage: $1,089Travel & lodging: $12
| Company | Payments | Amount |
|---|---|---|
| CeQur Corporation | 1 | $211 |
| Medtronic, Inc. | 5 | $187 |
| BETA BIONICS, INC. | 2 | $157 |
| Novo Nordisk Inc | 2 | $143 |
| Amgen Inc. | 2 | $138 |
| Insulet Corporation | 1 | $121 |
| Lilly USA, LLC | 3 | $71 |
| SANOFI-AVENTIS U.S. LLC | 1 | $45 |
| Madrigal Pharmaceuticals | 1 | $27 |
Products named: CeQur Simplicity, MINIMED 780G, iLet Bionic Pancreas, Ozempic, EVENITY, OMNIPOD, MOUNJARO, TZIELD.
Industry payments across MA — which companies pay providers there.
